Researchers discovered 13 gene mutations of significance in cervical cancer, including 8 mutations not previously linked to cervical cancer and 2 mutations novel to any type of cancer.
New research shows HAND2 gene methylation may have potential as a biomarker for early endometrial cancer detection and as a predictor of treatment response.
The use of oral contraceptives in women with BRCA1/2 mutations was associated with a reduced risk of ovarian cancer.
Female providers were twice as likely as their male counterparts to order HPV testing for low-risk women aged 30 to 65 who had normal Pap smear results.
A new index using protein markers can identify ovarian cancer cases at high and low risk for recurrence and discriminate between short- and long-term survivors.
An innovative, individualized vaccine that may prolong the remission period of ovarian cancer survivors has been developed. Will it work?
Researchers suggest that recommendations for the universal screening of breast cancer with mammography be reassessed.
Retinoids may have some effect on regression of certain grades of cervical intraepithelial neoplasia (CIN) but do not prevent disease progression.
Research shows that vaccinating all teens-both boys and girls--results in an enormous reduction in HPV-related infections. Why aren't we doing it in the United States?
Despite new screening guidelines, most obstetrician-gynecologists continue to perform annual pap tests, according to a recent survey of members of the American Congress of Obstetricians and Gynecologists (ACOG).